Loading clinical trials...
Loading clinical trials...
A Randomized, Double-blinded, Active Controlled, Single Dosing, Crossover Clinical Trial to Investigate the Pharmacokinetics, Pharmacodynamics and Safety of GBPD002 and Eprex® After Subcutaneous Administration in Healthy Adult Volunteers.
Conditions
Interventions
Erythropoietin alpha
Locations
2
Bangladesh
Globe Biotech Limited
Dhaka, Bangladesh
Farabi General Hospital
Dhaka, Bangladesh
Start Date
October 16, 2021
Primary Completion Date
November 14, 2021
Completion Date
December 16, 2021
Last Updated
October 20, 2022
Lead Sponsor
Globe Biotech Limited
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions